Actinium Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATNM and other ETFs, options, and stocks.

About ATNM

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. 

CEO
Sandesh Seth
CEOSandesh Seth
Employees
37
Employees37
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2000
Founded2000
Employees
37
Employees37

ATNM Key Statistics

Market cap
47.73M
Market cap47.73M
Price-Earnings ratio
-1.04
Price-Earnings ratio-1.04
Dividend yield
—
Dividend yield—
Average volume
296.48K
Average volume296.48K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$8.64
52 Week high$8.64
52 Week low
$1.03
52 Week low$1.03

People also own

Based on the portfolios of people who own ATNM. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Tilray Brands
NIO
Plug Power
Ocugen, Inc
Aurora Cannabis
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.